Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Cortical gray-white matter contrast alterations precede amyloid-β positivity and macrostructural changes in older adults without dementia.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Decreased amyloid-related structure-function coupling in preclinical Alzheimer's disease.

Communications medicine·2026
Same author

Longitudinal amyloid PET changes by cerebrospinal fluid amyloid and tau profiles in individuals with normal cognition: Role of <i>APOE</i> ε4.

Journal of Alzheimer's disease : JAD·2026
Same author

Class-level aggregation obscures clinically relevant heterogeneity in anti-amyloid antibody trials: comments on a Cochrane review by individual members of the EADC.

The journal of prevention of Alzheimer's disease·2026
Same author

GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy.

Nature communications·2026
Same author

Patients' and care partners' views on communicating the cause of dementia and related uncertainties: A qualitative study.

Journal of Alzheimer's disease : JAD·2026
Same journal

Multimorbidity burden and patterns associated with DeepBrainNet-derived brain-age gap in dementia-free older adults: A community-based study.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Reply to "Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities".

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Shifting the emphasis of brain health literacy from individuals to systems to reduce inequalities.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Correlates and predictors of self-efficacy among dementia caregivers: D-CARE findings.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

What should convince a clinician of disease modification in Alzheimer's disease clinical trials?

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same journal

Primary cilia-extracellular vesicle crosstalk in Alzheimer's disease: Emerging mechanisms and biomarker potential.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
查看所有相关文章

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Stephan Duijkers1, Inez H G B Ramakers1,2, Kim Massloh1

  • 1Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Limburg, Netherlands.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

诸如高血压和高胆固醇血症之类的并发症与阿尔茨海默氏病 (AD) 病理学有关,这种病理学存在于具有正常认知和轻度认知障碍的个体中. 这些条件对粉样β和生物标志物产生差异性影响,影响AD诊断.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经学 神经学
  • 生物标志物 生物标志物
  • 衰老研究研究 衰老研究

背景情况:

  • 全球人口老龄化,导致阿尔茨海默病 (AD) 和相关疾病的发病率增加.
  • 高血压 (HT),糖尿病 (DM) 和高胆固醇血症 (HCHOL) 是已知的痴呆症的危险因素.
  • 这些并发症组合与阿尔茨海默病神经病理学之间的具体关联仍然不清楚.

研究的目的:

  • 研究HT,DM和HCHOL的组合与AD病理的脑脊液 (CSF) 生物标志物之间的关联.
  • 检查这些并发症与粉样β 42 (A) 和酸化 (T) 水平之间的关系.

主要方法:

  • 分析了2479名正常认知 (NC) 和1618名轻度认知障碍 (MCI) 的参与者,这些参与者来自粉样蛋白生物标志物研究.
  • 基于HT,DM或HCHOL存在的参与者的分类 (没有,一个或两个或更多的并发症).
  • 使用数据驱动的切断值创建了四个粉样蛋白-β (A) 和酸化 (T) 生物标志物 (A-T-, A+T-, A-T+, A+T+) 档案.

主要成果:

  • 在NC个体中,并发症与较高的A+T-配置文件和较低的A-T-配置文件有关.
  • 在MCI患者中,并发症与较高的AT+配置文件和较低的AT-或AT+T+配置文件有关.
  • 高血压和高胆固醇血症在NC和MCI两组中都与改变的AT生物标志物概况特别相关,而DM没有显著的差异关联.

结论:

  • 伴随性疾病状态在正常认知和轻度认知障碍中不同地影响AD生物标志物概况.
  • 高血压和高胆固醇血症,但不是糖尿病,显示与粉样蛋白和病理的明显关联.
  • 研究结果表明,在记忆诊所的诊断策略中,考虑到并发症概况,可能会产生潜在的影响.